News stories about Neothetics (NASDAQ:NEOT) have been trending somewhat positive on Wednesday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Neothetics earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 45.4823483616356 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Shares of Neothetics (NEOT) opened at $1.25 on Wednesday. Neothetics has a 12 month low of $0.30 and a 12 month high of $2.63.

Neothetics (NASDAQ:NEOT) last announced its earnings results on Wednesday, November 8th. The biotechnology company reported ($0.13) earnings per share for the quarter.

Separately, ValuEngine upgraded Neothetics from a “strong sell” rating to a “sell” rating in a research report on Tuesday, October 17th.

COPYRIGHT VIOLATION NOTICE: “Neothetics (NEOT) Getting Somewhat Positive Media Coverage, Analysis Finds” was reported by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of US and international copyright & trademark laws. The correct version of this story can be accessed at

Neothetics Company Profile

Neothetics, Inc is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

Insider Buying and Selling by Quarter for Neothetics (NASDAQ:NEOT)

Receive News & Ratings for Neothetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neothetics Inc. and related companies with's FREE daily email newsletter.